A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer.

Tyrrell, C J; Kaisary, A V; Iversen, P; Anderson, J B; Baert, L; Tammela, T; Chamberlain, M; Webster, A; Blackledge, G

Tyrrell, C J; Kaisary, A V; Iversen, P; Anderson, J B; Baert, L; Tammela, T; Chamberlain, M; Webster, A; Blackledge, G.

Affiliation

Tyrrell CJ; Derriford Hospital, Plymouth, UK.

Eur Urol ; 33(5): 447-56, 1998.

Article in En | MEDLINE | ID: mdl-9643663

Subject(s)

Androgen Antagonists/therapeutic use; Anilides/therapeutic use; Castration; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/surgery; Aged; Aged, 80 and over; Androgen Antagonists/adverse effects; Anilides/adverse effects; Bone Neoplasms/drug therapy; Bone Neoplasms/secondary; Castration/adverse effects; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nitriles; Probability; Prognosis; Prostate-Specific Antigen/analysis; Prostatic Neoplasms/diagnosis; Prostatic Neoplasms/mortality; Quality of Life; Survival Rate; Tosyl Compounds; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Castration / Androgen Antagonists / Anilides Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 1998 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links